Compare Prodia Widyahusada Tbk. (PRDA) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Prodia Widyahusada Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Prodia Widyahusada Tbk. trades at Rp2,810 (market cap 2.63T, 861.1K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Prodia Widyahusada Tbk. is far larger — about 25.2× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| PRDA | SCPI | |
|---|---|---|
Market Cap | 2.63T | 104.4B |
Volume | 861.1K | — |
Lot | 8.61K | — |
Turnover | 2.42B | — |
Average Price | 2,806.54 | — |
Value | 2.42B | — |
Indicative Equilibrium Price | 2,810 | — |
Indicative Equilibrium Volume | 713 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Prodia Widyahusada Tbk.
PT Prodia Widyahusada Tbk (the Company) was established based on the Deed of Notary Sri Rahayu, SH, No. 14 dated February 8, 1988. Clinical Laboratory Prodia was first established in Solo, Central Java, on May 7, 1973 by a few idealists pharmaceutical educational background.
Read more on PRDA →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
